Groppi, Jr.; Vincent E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Groppi, Jr.; Vincent E..The latest application filed is for "double mutant alpha-7 nicotinic acetylcholine receptors".

Company Profile

0.17.0

Groppi, Jr.; Vincent E. - Kalamazoo MI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Double mutant alpha-7 nicotinic acetylcholine receptors Grant 7,247,706 - Groppi, Jr. , et al. July 24, 2	2007-07-24
1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease Grant 7,176,198 - Piotrowski , et al. February 13, 2	2007-02-13
Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease Grant 7,067,515 - Wishka , et al. June 27, 2	2006-06-27
Azabicyclic compounds for the treatment of disease Grant 7,001,900 - Jacobsen , et al. February 21, 2	2006-02-21
Azabicyclic-phenyl-fused-heterocyclic compounds for treatment of disease Grant 6,951,868 - Walker , et al. October 4, 2	2005-10-04
Azabicyclic-substituted-heteroaryl compounds for the treatment of disease Grant 6,919,359 - Piotrowski , et al. July 19, 2	2005-07-19
Substituted azabicyclic moieties for the treatment of disease Grant 6,869,946 - Jacobsen , et al. March 22, 2	2005-03-22
Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of disease Grant 6,858,613 - Rogers , et al. February 22, 2	2005-02-22
Substituted-aryl compounds for treatment of disease Grant 6,852,716 - Walker , et al. February 8, 2	2005-02-08
N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease Grant 6,849,620 - Walker , et al. February 1, 2	2005-02-01
Quinuclidine-substituted hetero-bicyclic aromatic compounds for the treatment of disease Grant 6,828,330 - Walker , et al. December 7, 2	2004-12-07
Double mutant alpha-7 nicotinic acetylcholine receptor Grant 6,693,172 - Groppi, Jr. , et al. February 17, 2	2004-02-17
Quinuclidine-substituted heteroaryl moieties for treatment of disease Grant 6,599,916 - Myers , et al. July 29, 2	2003-07-29
Quinuclidine-substituted heteroaryl moieties for treatment of disease Grant 6,500,840 - Myers , et al. December 31, 2	2002-12-31
Quinuclidine-substituted aryl compounds for treatment of disease Grant 6,492,386 - Myers , et al. December 10, 2	2002-12-10
Quinuclidine-substituted aryl compounds for treatment of disease Grant 6,486,172 - Myers , et al. November 26, 2	2002-11-26
Quinuclidine-substituted aryl compounds for treatment of disease Grant 6,479,510 - Myers , et al. November 12, 2	2002-11-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.